HIV protease inhibitor nelfinavir inhibits replication of SARS-associated coronavirus

A novel coronavirus has been identified as an etiological agent of severe acute respiratory syndrome (SARS). To rapidly identify anti-SARS drugs available for clinical use, we screened a set of compounds that included antiviral drugs already in wide use. Here we report that the HIV-1 protease inhibi...

Descripción completa

Detalles Bibliográficos
Autores principales: Yamamoto, Norio, Yang, Rongge, Yoshinaka, Yoshiyuki, Amari, Shinji, Nakano, Tatsuya, Cinatl, Jindrich, Rabenau, Holger, Doerr, Hans Wilhelm, Hunsmann, Gerhard, Otaka, Akira, Tamamura, Hirokazu, Fujii, Nobutaka, Yamamoto, Naoki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Inc. 2004
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7111005/
https://www.ncbi.nlm.nih.gov/pubmed/15144898
http://dx.doi.org/10.1016/j.bbrc.2004.04.083

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7111005/
https://www.ncbi.nlm.nih.gov/pubmed/15144898
http://dx.doi.org/10.1016/j.bbrc.2004.04.083

Ejemplares similares